As of June.1, 2023
Board Members
Motoo Ueno | President / Senior Advisor, Chugai Pharmaceutical Co., Ltd. |
---|---|
Tetsuo Nagano | Managing Director / Professor Emeritus, The University of Tokyo |
Hisanori Takanashi | Executive Director / Corporate Adviser, Chugai Pharmaceutical Co.,Ltd. |
Hirotoshi Akita | Director / Specially Appointed Professor, Professor Emeritus, Research Division of Cancer Immunotherapy, Hokkaido University Hospital, Hokkaido University |
Hidenori Ichijo | Director / Professor, Lab. of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo |
Tamao Endo | Director / Senior Fellow, Tokyo Metropolitan Institute for Geriatrics and Gerontology |
Toshio Kitamura | Director / Director, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe |
Osamu Nagayama | Director / Honorary Chairman, Chugai Pharmaceutical Co.,Ltd. |
Masahiro Nishijima | Director / National Institute of Health Sciences / Counterfeit and Illegal Drugs Information Center |
Toshifumi Hibi | Director / Honorary Professor, Keio University, School of Medicine |
Kohei Miyazono | Director / Executive Director, RIKEN, Distinguished University Professor, Graduate School of Medicine, The University of Tokyo |
Morito Monden | Director / President, Sakai City Hospital Organization |
Toshiaki Itagaki | Auditor / Director, Executive Vice President & CFO, Chugai Pharmaceutical Co.,Ltd. |
Masayoshi Kanai | Auditor / Certified Public Accountant, Kanai CPA Office |
Councilors
Hiroji Iwata | Vice director and Chief of Breast Oncology, Aichi Cancer Center Hospital |
---|---|
Masato Kasuga | Director, The Institute of Medical Science, Asahi Life Foundation |
Tatsuhiko Kodama | Project Leader, Cancer and Metabolism Project, RCAST, The University of Tokyo |
Takaki Shimada | Professor, Director of Center, Center for Preventive Medicine |
Mikiko Sodeoka | Chief Scientist, RIKEN |
Masakuni Degawa | Emeritus & Visiting Professor, University of Shizuoka |
Tetsuo Noda | Representative Director, Executive Director, Institute Director, Japanese Foundation for Cancer Research |
Kazuichi Hayakawa | Professor Emeritus, Institute of Nature and Environmental Technology, Kanazawa University |
Yasunobu Hirata | Honorary Director, Tokyo Teishin Hospital |
Taro Matsumoto | Professor, Nihon University School of Medicine |
Shuki Mizutani | Professor Emeritus, Tokyo Medical and Dental University |
Mariko Y Momoi | Professor Emeritus, Jichi Medical University |
Hisafumi Yamada | Director, Executive Vice President, Chugai Pharmaceutical Co.,Ltd. |
Mamoru Watanabe | Distinguished Professor, Tokyo Medical and Dental University, Advanced Research Institute |
Selection Committee Members
Satomi Adachi-Akahane | Professor, Department of Physiology, Faculty of Medicine, Toho University |
---|---|
Makoto Arita | Professor, Division of Physiological Chemistry and Metabolism, Keio University Faculty of Pharmacy |
Akiko Ishii-Watabe | Director, Division of Biological Chemistry and Biologicals, National Institute of Health Sciences |
Yutaka Inagaki | Professor, Tokai University School of Medicine |
Johji Inazawa | Director, Specifically Appointed Professor, Research Core Center, Tokyo Medical and Dental University (TMDU) |
Hideshi Inoue | Professor Emeritus, Specially Appointed Professor, Tokyo University of Pharmacy and Life Sciences |
Shin Enosawa | Research Associate, National Center for Child Health and Development |
Akio Ojida | Professor, Pharmaceutical Sciences, Kyushu University |
Takio Kitazawa | Emeritus Professor, Rakuno Gakuen University |
Hitoshi Kiyoi | Professor, Department of Hematology and Oncology, Nagoya University Grauate School of Medicine |
Yoshiaki Kubota | Professor, Department of Anatomy, Keio University School of Medicine |
Shoichiro Kurata | Professor, Graduate School of Pharmaceutical Sciences, Tohoku University |
Fumie Kobayashi | Eminent Professor, Azabu University |
Kiyosei Takasu | Professor, Graduate School of Pharmaceutical Sciences, Kyoto University |
Hideyo Takahashi | Professor, Faculty of Pharmaceutical Sciences, Tokyo University of Science |
Hitoshi Takizawa | Director and Professor, International Research Center for Medical Sciences, Kumamoto University |
Masahiro Tsuboi | Department of Director and Chief, Deoartment of Thoracic Suregry, National Cancer Center Hospital East |
Hidehiko Nakagawa | Professor, Graduate School of Pharmaceutical Sciences, Nagoya City University |
Kazuo Nagasawa | Professor, Tokyo University of Agriculture and Technology |
Hiroshi Nishina | Director & Professor, Medical Research Institute, Tokyo Medical and Dental University |
Kiyohiko Hatake | Professor, Department of Hematology, Akasaka Sanno Medical Center |
Kenjiro Hanaoka | Professor, Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University |
Ryuji Hamamoto | Division Chief, Division of Medical AI Research and Development, National Cancer Center Research Institute |
Akiyoshi Fukamizu | Professor, Director, Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba |
Naoya Fujita | Center Director, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research |
Shigeo Murata | Professor, Graduate School of Pharmaceutical Sciences, the University of Tokyo |
Masato Yasui | Professor and Chair, Department of Pharmacology, Keio University School of Medicine |
Yuji Yamanashi | Professor, Division of Genetics, The Institute of Medical Science, The University of Tokyo |
Kazuo Yamamoto | Professor, Department of Molecular and Tumor Pathology, Graduate School of Medicine, Chiba University |
Kouichi Yoshinari | Professor, School of Pharmaceutical Sciences, University of Shizuoka |
IAAO Advisory Board Members
Bruce A. Chabner | Professor, Harvard Medical School, USA |
---|---|
Kiyohiko Hatake | Professor, Department of Hematology, Akasaka Sanno Medical Center |
Chikashi Ishioka | Professor, Tohoku University of School of Medicine, Japan |
Yuko Kitagawa | Professor, Keio University of School of Medicine, Japan |
Hiroyuki Mano | Director, National Cancer Center Research Institute, Japan |
Kohei Miyazono | Executive Director, RIKEN, Distinguished University Professor, Graduate School of Medicine, The University of Tokyo |
Hitoshi Nakagama | President, National Cancer Center, Japan |
Hiroyoshi Nishikawa | Chief, Division of Cancer Immunology, Research Institute/ Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Japan |
Neal Rosen | Chair, Medical Oncology, Memorial Sloan Kettering Cancer Center, USA |
Josep Tabernero | Director, Vall d’Hebron Institute of Oncology (VHIO), Spain |
Masakazu Toi | Director, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan |
C-FINDs Staff
Toshikazu Urabe | Secretary General |
---|---|
Shigetaka Kato | Senior Manager |
Taro Miyazaki | Senior Manager, Editor-in-Chief |
Hirotaka Hasegawa | Senior Manager |
Mizue Haga | Senior Manager |
Hatsumi Furuta | Secretary Assistant |
Mitsumasa Saito | Accountant |
Yukiyo Uede | Accountant |